Investing Ideas
/
Swiss Pharmaceuticals & Biotech Most Popular Stocks

Swiss Pharmaceuticals & Biotech Most Popular Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Most Popular Stocks on the market

24 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ROG Roche Holding	CHF 289.00	1.0%	28.5%	CHF 231.9b	CHF 307.34	PE27.8x	E14.3%	3.4%
NOVN Novartis	CHF 96.83	1.3%	9.6%	CHF 191.2b	CHF 104.41	PE17.6x	E7.3%	3.6%
LONN Lonza Group	CHF 603.80	3.7%	35.9%	CHF 43.6b	CHF 657.95	PE68.6x	E21.1%	0.7%
GALD Galderma Group	CHF 115.70	4.5%	n/a	CHF 27.5b	CHF 104.26	PS7x	E36.6%	n/a
SDZ Sandoz Group	CHF 44.07	1.0%	59.2%	CHF 19.3b	CHF 44.39	PS2.1x	E29.5%	1.0%
SFZN Siegfried Holding	CHF 1,046.00	1.8%	18.4%	CHF 4.5b	CHF 1,167.67	PE34.8x	E13.0%	0.3%
BANB Bachem Holding	CHF 56.00	-4.2%	-5.7%	CHF 4.2b	CHF 76.00	PE37x	E17.8%	1.4%
DESN Dottikon ES Holding	CHF 213.50	-2.5%	-6.8%	CHF 2.9b	CHF 350.00	PE39.1x	S16.4%	0%
TECN Tecan Group	CHF 213.00	-9.7%	-36.9%	CHF 2.7b	CHF 283.83	PE27x	E13.9%	1.4%
SKAN SKAN Group	CHF 77.60	-1.6%	-2.3%	CHF 1.7b	CHF 90.67	PE54.1x	E17.8%	0.5%
COPN Cosmo Pharmaceuticals	CHF 63.00	-4.4%	-0.6%	CHF 1.0b	CHF 98.37	PE15.5x	E21.5%	3.0%
KURN Kuros Biosciences	CHF 22.30	-2.8%	337.3%	CHF 845.8m	n/a	PS16.1x	n/a	n/a
PPGN PolyPeptide Group	CHF 23.45	-8.6%	46.8%	CHF 773.5m	CHF 36.16	PS2.5x	E64.9%	0%
BSLN Basilea Pharmaceutica	CHF 40.30	-1.0%	24.2%	CHF 488.6m	CHF 77.25	PS3.3x	E14.9%	0%
SANN Santhera Pharmaceuticals Holding	CHF 16.52	-3.5%	75.6%	CHF 208.1m	CHF 25.00	PE3.3x	S-74.4%	n/a
BIOV New BioVersys	CHF 35.15	n/a	n/a	CHF 203.0m	n/a	n/a	n/a	n/a
NWRN Newron Pharmaceuticals	CHF 9.72	2.7%	12.8%	CHF 194.0m	CHF 15.64	PS29.6x	E40.4%	n/a
MOLN Molecular Partners	CHF 4.41	-8.2%	8.8%	CHF 162.4m	CHF 9.75	PS27.1x	E-9.2%	n/a
IDIA Idorsia	CHF 0.73	3.1%	-49.9%	CHF 137.0m	CHF 1.00	PS1.8x	E17.4%	n/a
XLS Xlife Sciences	CHF 21.20	1.9%	-54.2%	CHF 121.7m	n/a	PE5.7x	n/a	n/a
CURN Curatis Holding	CHF 12.60	-3.1%	n/a	CHF 61.1m	CHF 20.00	n/a	n/a	n/a
RLF Relief Therapeutics Holding	CHF 3.29	-12.3%	103.1%	CHF 41.3m	n/a	PS4.8x	n/a	n/a
ADXN Addex Therapeutics	CHF 0.062	2.3%	-17.0%	CHF 6.1m	CHF 0.16	PS10.2x	E18.5%	n/a
SPEX Spexis	CHF 0.012	20.0%	-94.2%	CHF 676.6k	n/a	PS1.4x	n/a	n/a

Page 1 of 1